Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, ...

GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced the presentation of ...

Portage Biotech Inc.'s (PRTG) shares soared over 27% on Monday, marking their best session in more than three weeks, after ...

Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the European Commission (EC) has granted conditional marketing ...

Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...

Hong Kong-based Akeso has announced that the US Food and Drug Administration (FDA) has approved its PD-1 monoclonal antibody, penpulimab-kcqx, alongside cisplatin or carboplatin and gemcitabine, for ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

Poon says that eating dragon fruit regularly has been linked to “better lipid profiles—lower LDL (‘bad’) cholesterol and ...

A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.

Exactech, a global medical technology leader, announced the international debut of GPS Ankle, the world's first navigation ...

Sophisticated imaging techniques have now revealed that when a booster vaccine is given in the same location, those ...